Sign in
4

Changes in Ownership

KYNTRA BIO, INC. Filed Acc 0001209191-23-021138

Chief Commercial Officer sold 905 shares at $18.71 ($16,933)

From the SEC's structured data for this filing

Trades in this filing

Wettig Thane · Chief Commercial Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2023-03-23 Sale : show line 1 in the form −905 $18.71 $16,933 110,653 D
Open-market sales · 905 sh · avg $18.71 · $16,933
Loading xslF345X04/doc4.xml…